Fig. 3.

Variations of circulating antibodies within 12 months of follow-up in LN patients

Variations of circulating levels of each antibody from T₀ were determined after 12 months of follow-up in LN patients. The decrement of proteinuria is reported for comparison. It is shown that anti-ENO1 and anti-ANXA1 had the maximal decrement and that anti-dsDNA had no variation at all. Results are shown as median and interquartile range. *indicates a statistical difference between anti-dsDNA and anti-ANXA1 with anti-ENO1.